Sean G. Trapp
24Patents
8h-index
27Co-inventors
71Inventor score
Filing activity: Nov 17, 1998 → Mar 4, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6670376B1 | Aryl aniline &bgr;2 adrenergic receptor agonists | Chemistry; Metallurgy | 62 | Expired |
| US7279458B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Chemistry; Metallurgy | 36 | Expired |
| US6392012B1 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Human Necessities | 35 | Expired |
| US6878686B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7067482B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Chemistry; Metallurgy | 29 | Expired |
| US6995138B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6444786B1 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Human Necessities | 22 | Expired |
| US6455669B1 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Human Necessities | 17 | Expired |
| US8153686B2 | Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Chemistry; Metallurgy | 5 | Active |
| US8101791B2 | Aminotetralin compounds as mu opioid receptor antagonists | Chemistry; Metallurgy | 5 | Active |
| US8314128B2 | Aminotetralin compounds as mu opioid receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US8106232B2 | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Emerging Cross-Sectional Technologies | 4 | Active |
| US7622467B2 | Aryl aniline derivatives as β2 adrenergic receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US8084417B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Emerging Cross-Sectional Technologies | 1 | Active |
| US8318765B2 | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
| US6962970B2 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Human Necessities | 1 | Expired |
| US6150379A | Compounds and compositions as anticoagulants | Chemistry; Metallurgy | 1 | Expired |
| US7582765B2 | Aryl aniline β2 adrenergic receptor agonists | Chemistry; Metallurgy | 1 | Active |
| US8497287B2 | Aminotetralin compounds as mu opioid receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US8952031B2 | Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8703791B2 | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Emerging Cross-Sectional Technologies | 0 | Active |
| US7723470B2 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Human Necessities | 0 | Active |
| US8969370B2 | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | Emerging Cross-Sectional Technologies | 0 | Active |
| US7994165B2 | Aryl aniline derivatives as β2 adrenergic receptor agonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.